Gastrointestinal Agents Concept

subject area of

• 10‐biomarker algorithm to identify irritable bowel syndrome  Journal Articles
• A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study  Journal Articles
• A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease  Journal Articles
• A response to Farup and Bytzer  Journal Articles
• ACG and CAG Clinical Guideline: Management of Dyspepsia  Journal Articles
• Adult patients with short bowel syndrome treated with teduglutide: A descriptive cohort study  Journal Articles
• An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease  Journal Articles
• An Update of The Cochrane Systematic Review of Helicobacter Pylori Eradication Therapy in Nonulcer Dyspepsia: Resolving The Discrepancy Between Systematic Reviews  Journal Articles
• An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.  Journal Articles
• BDNF and PDE4, but not the GRPR, Regulate Viability of Human Medulloblastoma Cells  Journal Articles
• Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease  Journal Articles
• Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease  Journal Articles
• Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease  Journal Articles
• Cisapride: The Problem of the Heart  Journal Articles
• Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus  Journal Articles
• Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues  Journal Articles
• Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series  Journal Articles
• Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis  Journal Articles
• Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn’s Disease: A Systematic Review and Network Meta-Analysis  Journal Articles
• Comparing the efficacy of vedolizumab between males and females: a post-hoc analysis of GEMINI-1 and VARSITY  Journal Articles
• Controversies Around Measuring Drug Toxicity: US Food and Drug Administration and Gastrointestinal Perspectives  Journal Articles
• Current Guidelines for Dyspepsia Management  Journal Articles
• Current Guidelines on Stress Ulcer Prophylaxis  Journal Articles
• Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab  Journal Articles
• Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease  Journal Articles
• Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?  Journal Articles
• Does the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey‐based study  Journal Articles
• Dyspepsia  Journal Articles
• Dyspepsia  Journal Articles
• Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis  Journal Articles
• Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis  Journal Articles
• Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis  Journal Articles
• End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn’s Disease  Journal Articles
• Eradication of Helicobacter pylori for non-ulcer dyspepsia  Journal Articles
• Eradication of Helicobacter pylori for non-ulcer dyspepsia  Journal Articles
• Eradication of Helicobacter pylori for non-ulcer dyspepsia  Journal Articles
• Eradication of Helicobacter pylori for non-ulcer dyspepsia.  Journal Articles
• Eradication of helicobacter pylori for non-ulcer dyspepsia.  Journal Articles
• Erythromycin for feeding intolerance in preterm infants  Journal Articles
• Erythromycin for feeding intolerance in preterm infants.  Journal Articles
• Erythromycin for the prevention and treatment of feeding intolerance in preterm infants  Journal Articles
• Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments  Journal Articles
• Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey  Journal Articles
• Gastro-oesophageal reflux disease.  Journal Articles
• Gastro-oesophageal reflux disease.  Journal Articles
• Gastro-oesophageal reflux disease.  Journal Articles
• Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease  Journal Articles
• Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia.  Journal Articles
• Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors  Journal Articles
• Initial management strategies for dyspepsia  Journal Articles
• Initial management strategies for dyspepsia  Journal Articles
• Initial management strategies for dyspepsia  Journal Articles
• Initial management strategies for dyspepsia.  Journal Articles
• Initial management strategies for dyspepsia.  Journal Articles
• Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal motor disorders  Journal Articles
• Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial  Journal Articles
• Letter: mucosal healing is associated with improved long‐term outcomes in Crohn's disease – authors' reply  Journal Articles
• Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study  Journal Articles
• Management of Opioid-Induced and Non–Opioid-Related Constipation in Patients With Cancer: Systematic Review and Meta-Analysis  Journal Articles
• Management of reflux-related symptoms  Journal Articles
• New Pharmacologic Approaches in Gastroesophageal Reflux Disease  Journal Articles
• New Pharmacologic Approaches in Gastroesophageal Reflux Disease  Journal Articles
• No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease  Journal Articles
• Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium  Journal Articles
• Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn’s Disease: A Post-hoc Analysis  Journal Articles
• Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease.  Journal Articles
• Pancreatic Enzyme Supplements Are Not Effective for Relieving Abdominal Pain in Patients with Chronic Pancreatitis: Meta-Analysis and Systematic Review of Randomized Controlled Trials  Journal Articles
• Patterns of antiemetic medication use during pregnancy: A multi-country retrospective cohort study  Journal Articles
• Pharmacological Therapies for the Management of Fistulizing Crohn’s Disease: A Systematic Review and Meta-Analysis  Journal Articles
• Pharmacological interventions for non-ulcer dyspepsia  Journal Articles
• Pharmacological interventions for non-ulcer dyspepsia  Journal Articles
• Pharmacological interventions for non-ulcer dyspepsia  Journal Articles
• Pharmacological interventions for non-ulcer dyspepsia  Journal Articles
• Pharmacological interventions for non-ulcer dyspepsia.  Journal Articles
• Placebo Rates in Crohn's Disease Randomized Clinical Trials: An Individual Patient Data Meta-Analysis.  Journal Articles
• Preferences on the Use of Prokinetic Agents in Adult Intensive Care Unit Patients-An International Survey.  Journal Articles
• Prevalence of endoscopic improvement and remission according to patient‐reported outcomes in ulcerative colitis  Journal Articles
• Prokinetic agents in adult intensive care unit patients (PATIENCE)-An international inception cohort study protocol.  Journal Articles
• Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials  Journal Articles
• Prokinetics for functional dyspepsia  Journal Articles
• Recommendations on Chronic Constipation (including Constipation Associated with Irritable Bowel Syndrome) Treatment  Journal Articles
• Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis  Journal Articles
• Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease  Journal Articles
• Review article: current treatment options and management of functional dyspepsia  Journal Articles
• Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis  Journal Articles
• Severe Colitis in Children  Journal Articles
• Should we step‑up or step‑down in the treatment of new‑onset dyspepsia in primary care?  Journal Articles
• Sudden cardiac death & The Reverse Dodo Verdict  Journal Articles
• Systematic Review  Journal Articles
• Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids  Journal Articles
• Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease  Journal Articles
• Systematic review and meta‐analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease  Journal Articles
• Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome  Journal Articles
• Systematic review: antacids, H₂‐receptor antagonists, prokinetics, bismuth and sucralfate therapy for non‐ulcer dyspepsia  Journal Articles
• Systematic review: persistence and severity in gastro‐oesophageal reflux disease  Journal Articles
• The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium  Journal Articles
• The Second Canadian Gastroesophageal Reflux Disease Consensus: Moving Forward to New Concepts  Journal Articles
• The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies  Journal Articles
• The intestinal microbiome, probiotics and prebiotics in neurogastroenterology  Journal Articles
• The minimal detectable change cannot reliably replace the minimal important difference  Journal Articles
• Tracking gastrointestinal transit of solids in aged rats as pharmacological models of chronic dysmotility  Journal Articles
• Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents  Journal Articles
• Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease  Journal Articles
• Update from the Canadian Dyspepsia Working Group.  Journal Articles
• Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome  Journal Articles
• Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy  Journal Articles
• Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission  Journal Articles
• Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn’s Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials  Journal Articles